Invention Grant
US07799792B2 Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841
失效
代谢型谷氨酸受体恶二唑配体及其作为增效剂的用途841
- Patent Title: Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841
- Patent Title (中): 代谢型谷氨酸受体恶二唑配体及其作为增效剂的用途841
-
Application No.: US12134520Application Date: 2008-06-06
-
Publication No.: US07799792B2Publication Date: 2010-09-21
- Inventor: Joshua Clayton , Ian Egle , James Empfield , James Folmer , Methvin Isaac , Fupeng Ma , Abdelmalik Slassi
- Applicant: Joshua Clayton , Ian Egle , James Empfield , James Folmer , Methvin Isaac , Fupeng Ma , Abdelmalik Slassi
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agent Kenneth F. Mitchell
- Main IPC: A61K31/496
- IPC: A61K31/496 ; C07D413/04 ; C07D413/14 ; A61K31/4245
Abstract:
Compounds of Formula I: wherein R1, R2, R3, R4 and Q are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
Public/Granted literature
- US20080306088A1 Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators 841 Public/Granted day:2008-12-11
Information query
IPC分类:
